January 11, 2010 Vol. XXVII, No. 2 Sign up for our FREE PW e-newsletter Home Past Issues Search Register Contact Us Back to Phys Weekly  Popular Articles  1. Managing COPD: An Update on GOLD Standards 2. Making the Case for Advanced Directives 3. Preventing MRSA Transmission  Making The Rounds   Practice Management  The Emerging Digital Divide      Hospitals that disproportionately care for poor patients appear to be falling behind in adopting...  Clinical Update  Diagnosis of Gout May Be Seasonal      Data from the United Kingdom suggest that the incidence of gout is seasonal. New gout cases and...  Reading Room  A New Guide for Self-Managing MS      The Consortium of Multiple Sclerosis Centers has released a white paper, which analyzes patient...  Through The Pipeline  A Welcome Addition for Advanced RCC      The FDA has approved pazopanib (Votrient, GlaxoSmithKline) for use in treating patients with... Statin Gains Pediatric Indication      Rosuvastatin calcium (Crestor, AstraZeneca) has been approved by the FDA for a new indication.... This Week's Feature Story Depression During Pregnancy: New Recommendations      New guidance recommendations have been unveiled to help physicians and patients weigh the risks and benefits of various treatment interventions for depression during pregnancy. [ More ]  In The News  Assessing MDD & Mortality After ACS      The severity of major depressive disorder (MDD) measured within a few weeks of hospitalization for acute coronary syndrome (ACS) or failure of MDD to improve during the 6 months following ACS appears to predict more than a doubling of mortality over 6.7 years of follow-up. [ More ] Racial Disparities in Care for Hypertension      Patient race appears to be linked with the quality of patient-physician communication to a greater extent than blood pressure (BP) control. Investigators found that African Americans with uncontrolled BP had shorter visits with less biomedical, psychosocial, and rapport-building statements than Caucasians with controlled BP. [ More ] Slowing Cognitive Decline in Alzheimer’s      Treatment of vascular risk factors (VRF) in patients who have Alzheimer’s disease without cardiovascular disease appears to be associated with slower cognitive decline, according to a French study group. Patients with all their VRF treated experienced less cognitive decline than those with none of their VRF treated. [ More ]  In My Opinion...  Highlights From CHEST 2009   To get Physician's Weekly posted in your hospital, click HERE PW Archives | Past Issues | Register | Contact Us | Search Archive | Back To Top © 2010 Physician’s Weekly, LLC Web design and development by Spindustry Interactive™

There is no survey at this time.